Trade Summary

1 week ago, Southpoint Capital Advisors LP, serving as 10% owner at Fennec Pharmaceuticals Inc. (FENC), sold 1,000,000 shares at $7.50 per share, for a total transaction value of $7,500,000.00. Following this transaction, Southpoint Capital Advisors LP now holds 2,744,741 shares of FENC.

This sale represents a 27.00% decrease in Southpoint Capital Advisors LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, December 24, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 5 days after the trade was made.

Fennec Pharmaceuticals Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.